This article first appeared on GuruFocus.

Outset Medical Inc (NASDAQ:OM) is set to release its Q3 2025 earnings on Nov 10, 2025. The consensus estimate for Q3 2025 revenue is $30.88 million, and the earnings are expected to come in at -$0.98 per share. The full year 2025's revenue is expected to be $124.14 million and the earnings are expected to be -$5.16 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 5 Warning Signs with OM.

Is OM fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for Outset Medical Inc (NASDAQ:OM) have remained stable at $124.14 million for the full year 2025 and at $137 million for 2026 over the past 90 days. Earnings estimates have also remained unchanged at -$5.16 per share for the full year 2025 and at -$3.51 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, Outset Medical Inc's (NASDAQ:OM) actual revenue was $31.42 million, which beat analysts' revenue expectations of $29.41 million by 6.84%. Outset Medical Inc's (NASDAQ:OM) actual earnings were -$1.04 per share, which beat analysts' earnings expectations of -$1.12 per share by 6.73%. After releasing the results, Outset Medical Inc (NASDAQ:OM) was up by 7.67% in one day.

Based on the one-year price targets offered by 4 analysts, the average target price for Outset Medical Inc (NASDAQ:OM) is $25.75 with a high estimate of $39.00 and a low estimate of $17.00. The average target implies an upside of 118.04% from the current price of $11.81.

Based on GuruFocus estimates, the estimated GF Value for Outset Medical Inc (NASDAQ:OM) in one year is $11.59, suggesting a downside of -1.86% from the current price of $11.81.

Based on the consensus recommendation from 5 brokerage firms, Outset Medical Inc's (NASDAQ:OM) average brokerage recommendation is currently 2.0, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.